- Home
- ACMR vs LEGN Comparison
ACMR vs LEGN Comparison
Compare ACMR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACMR | LEGN |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.9B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACMR | LEGN |
|---|---|---|
| Price | $84.21 | $22.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $50.00 | ★ $61.33 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $74,643,000.00 | N/A |
| Revenue This Year | $29.37 | $42.68 |
| Revenue Next Year | $23.16 | $30.52 |
| P/E Ratio | $368.42 | ★ N/A |
| Revenue Growth | ★ 104.47 | N/A |
| 52 Week Low | $23.03 | $16.24 |
| 52 Week High | $127.19 | $43.71 |
Technical Indicators
Market Signals| Indicator | ACMR | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 32.37 |
| Support Level | $75.83 | $20.70 |
| Resistance Level | $94.21 | $23.68 |
| Average True Range (ATR) | 6.68 | 1.19 |
| MACD | -2.21 | -0.29 |
| Stochastic Oscillator | 21.36 | 4.81 |
Price Performance
Historical ComparisonAbout ACMR ACM Research Inc.
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.